Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1664

Apr 16, 2020

Mathematician John Horton Conway, a ‘magical genius’ known for inventing the ‘Game of Life,’ dies at age 82

Posted by in categories: biotech/medical, entertainment, mathematics

John Horton Conway, a legendary mathematician who stood out for his love of games and for bringing mathematics to the masses, died on Saturday, April 11, in New Brunswick, New Jersey, from complications related to COVID-19. He was 82.

Known for his unbounded curiosity and enthusiasm for subjects far beyond mathematics, Conway was a beloved figure in the hallways of Princeton’s mathematics building and at the Small World coffee shop on Nassau Street, where he engaged with students, faculty and mathematical hobbyists with equal interest.

Conway, who joined the faculty in 1987, was the John von Neumann Professor in Applied and Computational Mathematics and a professor of mathematics until 2013 when he transferred to emeritus status.

Apr 16, 2020

How will the COVID-19 pandemic end? A virologist explains

Posted by in categories: biotech/medical, education, robotics/AI

How and when will this pandemic end? We asked a virologist: https://bit.ly/3afDiMy from World Economic Forum P.S., Many people predict that life will be permanently changed after COVID-19 pandemic. Some new things will become the norm, such as remote working, #telemedicine, the increase of #automation, online education, and so on (e.g., https://bit.ly/2z6qF9I). Our opinion is that “whether the above things become permanent depends on how the pandemic ends.” If the virus becomes seasonal, as predicted by the virologist in the interview, then our lives may gradually shift towards these new practices (i.e., working remotely, seeing doctor remotely, and learning online, etc.). However, if the virus disappears abruptly, just like the 1918 Spanish flu (https://bit.ly/3bdJKop), our lives may slowly go back to what we used to know before the COVID-19 crisis.


We spoke to Belgian virologist Guido Vanham, the former head of virology at the Institute for Tropical Medicine in Antwerp, Belgium, and asked him: how will this pandemic end? And on which factors might that depend?

Continue reading “How will the COVID-19 pandemic end? A virologist explains” »

Apr 16, 2020

Can We Opt Out of Aging? | Greg Fahy | TEDxResedaBlvd

Posted by in categories: biotech/medical, genetics, life extension

NOTE FROM TED: Please do not look to this talk for medical advice. This talk only represents the speaker’s personal views and understanding of aging which remains an emerging field of study. We’ve flagged this talk because it falls outside the content guidelines TED gives TEDx organizers. TEDx events are independently organized by volunteers. The guidelines we give TEDx organizers are described in more detail here: http://storage.ted.com/tedx/manuals/tedx_content_guidelines.pdf

Could we reverse epigenetic aging by re-growing the thymus? In the future, will it be possible to extend our lives or increase our longevity? Dr. Greg Fahy is a low-temperature biologist and investigator of aging intervention in humans. His first clinical trial, intended to reverse immune system aging, provided evidence that aging could be reversed in humans. Dr. Greg Fahy is a low-temperature biologist and investigator of aging intervention in humans. His first clinical trial, intended to reverse immune system aging, provided the first evidence that global aging can be reversed in humans. This talk was given at a TEDx event using the TED conference format but independently organized by a local community.

Apr 16, 2020

‘Directing’ evolution to identify potential drugs earlier in discovery

Posted by in categories: biotech/medical, evolution

Help with covid-19 antibody treatment research?

Apr 16, 2020

Coronavirus Picks on Some Cells More Than Others

Posted by in category: biotech/medical

The virus may infect bronchial transient secretory cells more because of high levels of ACE2 and TMPRSS2.

Apr 16, 2020

Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection

Posted by in categories: biotech/medical, computing, health

Test Coronavirus in minutes:

The ongoing outbreak of the novel coronavirus disease (COVID-19) has spread globally and poses a threat to public health in more than 200 countries. Reliable laboratory diagnosis of the disease has been one of the foremost priorities for promoting public health interventions. The routinely used reverse transcription polymerase chain reaction (RT-PCR) is currently the reference method for COVID-19 diagnosis. However, it also reported a number of false-positive or –negative cases, especially in the early stages of the novel virus outbreak. In this work, a dual-functional plasmonic biosensor combining the plasmonic photothermal (PPT) effect and localized surface plasmon resonance (LSPR) sensing transduction provides an alternative and promising solution for the clinical COVID-19 diagnosis. The two-dimensional gold nanoislands (AuNIs) functionalized with complementary DNA receptors can perform a sensitive detection of the selected sequences from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through nucleic acid hybridization. For better sensing performance, the thermoplasmonic heat is generated on the same AuNIs chip when illuminated at their plasmonic resonance frequency. The localized PPT heat is capable to elevate the in situ hybridization temperature and facilitate the accurate discrimination of two similar gene sequences. Our dual-functional LSPR biosensor exhibits a high sensitivity toward the selected SARS-CoV-2 sequences with a lower detection limit down to the concentration of 0.22 pM and allows precise detection of the specific target in a multigene mixture. This study gains insight into the thermoplasmonic enhancement and its applicability in the nucleic acid tests and viral disease diagnosis.

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Continue reading “Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection” »

Apr 15, 2020

Why Copper Is Good at Killing Viruses

Posted by in category: biotech/medical

When researchers reported last month that the novel coronavirus causing the COVID-19 pandemic survives for days on glass and stainless steel but dies within hours after landing on copper, the only thing that surprised Bill Keevil was that the pathogen lasted so long on copper.

Apr 15, 2020

NIH study validates decontamination methods for re-use of N95 respirators

Posted by in category: biotech/medical

Three methods effectively sanitized masks for limited re-use.

Apr 15, 2020

Global Stock Losses Hit $6 Trillion As Virus Fear Spreads

Posted by in category: biotech/medical

Global stocks have lost at least $6 trillion in market value since Jan. 20 when the coronavirus outbreak first started becoming a concern for investors. The decline accelerated this week as the spread of cases outside of China picked up pace, sparking a worldwide sell-off that led to six straight sessions of losses for stocks through Thursday. Infections in South Korea have skyrocketed to more than 2,000 from less than 100 a week ago, while new cases in Italy and Iran have also seen a sharp up-t.

Apr 15, 2020

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Posted by in categories: biotech/medical, surveillance

It is urgent to understand the future of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission. We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave. Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded. To avoid this, prolonged or intermittent social distancing may be necessary into 2022. Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity. Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2. Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained since a resurgence in contagion could be possible as late as 2024.

The ongoing severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) pandemic has caused nearly 500,000 detected cases of coronavirus disease 2019 (COVID-19) illness and claimed over 20,000 lives worldwide as of 26 Mar 2020. Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4). With no pharmaceutical treatments available, interventions have focused on contact tracing, quarantine, and social distancing. The required intensity, duration, and urgency of these responses will depend both on how the initial pandemic wave unfolds and on the subsequent transmission dynamics of SARS-CoV-2. During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.